Atom engineering-regulated in situ transition of Cu(I)-Cu(II) for efficiently overcoming cancer drug resistance
Crossref DOI link: https://doi.org/10.1007/s11426-022-1340-6
Published Online: 2022-09-16
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Yuequn
Chen, Mingkai
Wang, Junping
Cai, Fei
Ma, Li
Chen, Tianfeng
Text and Data Mining valid from 2022-09-16
Version of Record valid from 2022-09-16
Article History
Received: 21 May 2022
Accepted: 19 July 2022
First Online: 16 September 2022
Ethics
: <b>Conflict of interest</b> The authors declare no conflict of interest.